Prognostic Implications of Physiologic Investigation After Revascularization With Stent
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Abdul Hakeem, MD
Rutgers Robert Wood Johnson Medical School
Principal Investigator - Akiko Matsuo, MD
Kyoto Second Red Cross Hospital, Kyoto, Japan
Principal Investigator - Bernard De Bruyne, MD, PhD
Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium
Principal Investigator - Bon-Kwon Koo, MD, PhD
Seoul National University Hospital, Seoul, South Korea
Study Chair - Hong-Seok Lim, MD, PhD
Ajou University Hospital, Suwon, South Korea
Principal Investigator - Joo Myung Lee, MD, PhD, MSc
Samsung Medical Center
Principal Investigator - Joon Hyung MD, PhD, MD, PhD
Inje University Ilsan Paik Hospital, Goyang, South Korea
Principal Investigator - Lorenzo Azzalini, MD, PhD
San Raffaele Scientific Institute, Milan, Italy
Principal Investigator - Massoud A. Leesar, MD, PhD, MSc
University of Cincinnati
Principal Investigator - Nils P. Johnson, MD, MS
McGovern Medical School at UTHealth and Memorial Hermann Hospital, TX, USA
Principal Investigator - Nobuhiro Tanaka, MD, PhD, MSc
Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
Principal Investigator - Shao-Liang Chen, MD
Nanjing First Hospital, Nanjing Medical University
Principal Investigator - Tsunekazu Kakuta, MD, PhD
Tsuchiura Kyodo General Hospital
Principal Investigator - Tsuyoshi Ito, MD
Nagoya City University Graduate School of Medical Science, Nagoya, Japan
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Seoul National University Hospital
Seoul, Select, South Korea
Bon-Kwon Koo, MD, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 May 2020
- Primary completion
- 28 Feb 2021
- Completion
- 28 Feb 2021
- Last update posted
- 26 Feb 2021
- Registered enrollment
- 5,100
- Registry id
- NCT04684043
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.